Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCAR -- Ignore unavailable to you. Want to Upgrade?

To: Ray Desori who wrote (62)	10/30/1997 9:48:00 AM
From: Bisset	Respond to of 467

Excellent comment about the move to NASDAQ, Ray... I have looked at many issues that have moved up from the pink sheets/ OTC to the "real" boards, and almost without exception, they have reacted similar to a forward stock split - they have increased share value by 10-20% or more... I have spoken with Bill Mann, head of MedCare's IR dept., and he noted that they have met all the requirements and submisssions, and it is just a matter of weeks until the news is released. Hell, even the day-traders should be interested in this one - with the new clinics opening and the impending upgrade to NASDAQ, MCAR's a no-brainer. On another note, I've been watching some of the competition (URMD), and it's like a deserted ghost town over there... some analyst-type guy named Joe Sing lambasted their basic company fundamentals and product line, and the hypesters ran for cover... too bad. <bg> John